Saving lives starts in the laboratory
Dr Hayley Bullen is undertaking dedicated research into new malaria drugs and requires an important piece of new equipment.
Donate today to help provide Burnet's labs with critical equipment.
Dr Hayley Bullen is undertaking dedicated research into new malaria drugs and requires an important piece of new equipment.
Donate today to help provide Burnet's labs with critical equipment.
Our dynamic, interdisciplinary team uses modelling to guide effective and cost-effective responses infectious diseases and global health problems. We are at the forefront of modelling across numerous thematic areas, including:
Our methodological approaches are adapted to the data available and key policy questions being addressed, and includes a variety of:
Discover more about Burnet’s modelling work in Episode 7 of our How Science Matters podcast
Head, Modelling & Biostatistics Group
COVASIM: Modelling COVID-19
Decision science using Optima
HCV Elimination Modelling
Healthy Mothers, Healthy Babies
Hepatitis B Modelling
HMHB - Health Services for Postnatal and Infancy Care
SimDrink: Using simulation modelling to perform alcohol policy experiments
The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
Aimée Altermatt
Research Assistant
Anna Roberts
Executive Business & Programs Manager, Optima Consortium for Decision Science
Anna Palmer
Honorary Associate
Chris Seaman
PhD Student
Professor David Wilson
Head of Infectious Disease Modelling
Doctor Debra ten Brink
Research Assistant
Dominic Delport
Research Assistant
Doctor Farah Houdroge
Mathematical Modeller
Doctor Katherine Heath
Research Officer
Doctor Nick Scott
Head, Modelling & Biostatistics Group
Doctor Rachel Sacks-Davis
Research Officer
Doctor Romesh Abeysuriya
Senior Research Officer – Computational Epidemic Modelling
Doctor Rowan Martin-Hughes
Senior Research Officer
Doctor Sherrie Kelly
Applications Team Lead
Doctor Tharindu Wickramaarachchi
Mathematical Modeller
Tom Tidhar
Research Assistant
Tom Walsh
Health Modeller
Accelerating towards elimination of vector-borne diseases such as malaria and lymphatic filariasis requires new approaches to diagnosis, surveillance and intervention.
There is an unmet need for new and/or improved tests for many diseases that predominantly affect disadvantaged populations.
Translating research into sustainable health solutions for vulnerable communities through health system strengthening, improved health service delivery and empowering communities.
Supporting national tuberculosis programs in the Asia-Pacific region to address drug-resistant tuberculosis.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2021 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
